Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII:C

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 3, 2002, Pages 137-142

  Ten Boekel, Edwin ^a   Bartels, Piet ^a  

^a Location Alkmaar   (Netherlands)

Author keywords

Factor VIII; Prothrombin fragment F1+2; Short APTT; Thrombin antithrombin III complex

Indexed keywords

BLOOD CLOTTING FACTOR 8C; D DIMER; TRANSACTIVATOR PROTEIN; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PROTHROMBIN; PROTHROMBIN FRAGMENT 1.2;

ARTICLE; DNA POLYMORPHISM; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INTERMETHOD COMPARISON; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK FACTOR; THROMBOGENESIS; THROMBOGENICITY; 3' UNTRANSLATED REGION; ACTIVATED PROTEIN C RESISTANCE; BLOOD; COHORT ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; PREVALENCE; PROMOTER REGION; PROSPECTIVE STUDY; THROMBOPHILIA;

3' UNTRANSLATED REGIONS; ACTIVATED PROTEIN C RESISTANCE; ANTITHROMBIN III; COHORT STUDIES; FACTOR V; FACTOR VIII; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PREVALENCE; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0036580367     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065217     Document Type: Article

References (24)

1. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1531.
2. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA: Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
4. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-155.
5. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M: High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to acute phase reaction. Thromb Haemost 1997;77:825-828.
6. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR: High plasma concentration of factor VIII:C is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
7. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S: High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-462.
8. McKenna R, Bachmann F, Miro-Quesada M: Thromboembolism in patients with abnormally short activated thromboplastin time. Thromb Haemost 1977;38:893-899.
9. Korte W, Clarke S, Lefkowitz JB: Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol 2000;113:123-127.
10. Reddy NM, Hall SW, MacKintosh FR: Partial thromboplastin time. Prediction of adverse events and poor prognosis by low abnormal values. Arch Intern Med 1999;159:2706-2710.
11. Gallus AS, Hirsh J, Gent M: Relevance of pre-operative and postoperative blood tests to postoperative leg-vein thrombosis. Lancet 1973;2:805-809.
12. Pilgeram LO: Abnormalities in clotting and thrombolysis as a risk factor for stroke. Thromb Diath Haemorrh 1974;31:245-264.
13. Salem HH, Whitworth JA, Koutts J, Kincaid-Smith PS, Firkin BG: Hypercoagulation in glomerulonephritis. Br Med J (Clin Res Ed) 1981;282:2083-2085.
14. Landi G, D'Angelo A, Boccardi E, et al: Venous thromboembolism in acute stroke: Prognostic importance of hypercoagulability. Arch Neurol 1992;49:279-283.
15. Guirguis N, Budisavljevic MN, Self S, Rajagopalan PR, Lazarchick J: Acute renal artery and vein thrombosis after renal transplant, associated with a short partial thromboplastin time and factor V Leiden mutation. Ann Clin Lab Sci 2000;30:75-78.
16. Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina PM, Turpie AG, Mannucci PM: Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT study. European Concerted Action on Thrombosis. Thromb Haemost 1999;81-879-886.
17. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987;70:343-350.
18. Humphries JE, Acker MN, Schnell DE, Knarr JW: Artifactual prolongation of the activated partial thromboplastin time mimicking a coagulopathy. Am J Clin Pathol 1993;100:108-110.
19. Mansveldt EP, Laffan M, McVey JH, Tuddenham EG: Analysis of the F8 gene in individuals with high plasma factor VIII:C levels and associated venous thrombosis. Thromb Haemost 1998;80:561-565.
20. O'Donnell J, Mumford AD, Manning RA, Laffan MA: Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 2001;115:687-691.
21. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H: Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997;97:775-784.
22. Bick RL: Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998;24:3-18.
23. Kyrle PA, Eichinger S, Pabinger I, Stumpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Melichart M, Traxler G, Weltermann A, Speiser W, Lechner K: Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism. Thromb Haemost 1997;77:829-833.
24. Bertina RM: The prothrombin 20210 G to A variation and thrombosis. Curr Opin Hematol 1998;5:339-342.